Best Options Strategy for RGNX
Looking for the best options strategy for REGENXBIO Inc. (RGNX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RGNX option chain right now, and a simple map from your view on RGNX to the strategy that fits it. Model any of them in the calculator before you trade.
About RGNX
REGENXBIO Inc. (RGNX) is a major company in Biotechnology. Options traders on RGNX tend to watch , since these can drive large moves in the share price.
About REGENXBIO Inc.
REGENXBIO Inc. is a biotechnology company developing gene therapies designed to correct genetic disorders by delivering functional genes to defective cells. The company's pipeline relies on NAV Technology Platform, a proprietary system using adeno-associated viruses to carry genetic material into target tissues. Its clinical candidates address serious conditions including wet age-related macular degeneration and diabetic retinopathy through ABBV-RGX-314, Duchenne muscular dystrophy via RGX-202, and two forms of mucopolysaccharidosis through RGX-121 and RGX-111. Beyond developing its own products, the company generates revenue by licensing the NAV platform to other pharmaceutical firms and biotechnology companies seeking to build their own gene therapy programs.
The company operates primarily through product development and platform licensing agreements. Its most advanced partnership involves AbbVie, which is advancing ABBV-RGX-314 in clinical trials. REGENXBIO has also partnered with Nippon Shinyaku to commercialize RGX-121 and RGX-111 outside the United States, expanding its geographic reach through these arrangements. Founded in 2008 and based in Rockville, Maryland, the…
Today's top-scoring strategy for RGNX
Our engine ranks defined-risk strategies on the live RGNX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $7 | $0.15 |
| Sell | 1× | PUT | $10 | $0.30 |
| Sell | 1× | CALL | $16 | $1.60 |
| Buy | 1× | CALL | $19 | $0.30 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Live scan from 2026-07-02 · quotes delayed ~15 minutes
Implied volatility
RGNX is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 118% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on RGNX currently price in about 118% implied volatility, versus roughly 98% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$3.11 (±23%) in RGNX by 2026-07-17 — a range of roughly $10.24 to $16.46. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, upside calls on RGNX carry a higher implied volatility than downside puts — demand is tilted to the upside, which favours call spreads or selling cash-secured puts.
Liquidity and tradeability
RGNX options are thinly traded, with wide bid-ask spreads around 45.2% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
RGNX's next earnings report is due around August 6, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $687M
- Beta (vs market)
- 1.03
- 52-week range
- $5.46–$16.19 (74% up the range)
- Short interest
- 19.3% of float · 5.4 days to cover
With 19.3% of RGNX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for RGNX
Start with your outlook on RGNX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while RGNX stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open RGNX in the free calculator →
Frequently asked questions
What is the best options strategy for RGNX?
It depends on your outlook. Bullish traders often use a long call or bull call spread on RGNX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are RGNX options liquid enough to trade?
REGENXBIO Inc. (RGNX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade RGNX options?
Buying a single RGNX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RGNX or any security. Do your own research.
What does REGENXBIO Inc. do?
REGENXBIO Inc. (RGNX) operates in the Biotechnology industry. The "About REGENXBIO Inc." section above gives a fuller picture of what the company does and how it earns money.
Does REGENXBIO Inc. pay a dividend?
REGENXBIO Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
When does REGENXBIO Inc. next report earnings?
REGENXBIO Inc.'s next earnings are expected around August 6, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to RGNX
Comparing RGNX with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 9804 Medical Center Drive, Rockville, MD, 20850, United States
- Industry
- Biotechnology
- Employees
- 371
- CEO
- Mr. Curran M. Simpson M.S.
- Phone
- 240 552 8181
- Website
- www.regenxbio.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.